Ripac-Labor GmbH

Ripac-Labor GmbH

Ripac-Labor GmbH

Our company`s name RIPAC is made up from the different poultry pathogens we work with: Riemerella, the closely related Pasteurella, E.coli and Clostridia. Based on the expertise of the veterinaries Dr. habil. B. Köhler and Dr. Senf the company was founded in 2003. Since then we have served different clients in Germany and other countries around the world with our expertise in characterisation and immunological treatment of Riemerella- and Clostridia infections in poultry flocks. We offer high quality diagnostics and development of specific vaccines for bacterial infections of poultry and other animals. Furthermore, we offer resistance tests on the basis of pathogen characterisation and pathogen serotyping and epidemiological analysis of actual occurring infections. The RIPAC-Laboratory is among the top laboratories working on Riemerella inflicted infections, which is one of the worst threats to water poultry worldwide.

Company details

Am Muehlenberg 11 , Potsdam-Golm , 14476 Germany
View in map

Find locations served, office locations

Business Type:
Industry Type:
Market Focus:
Globally (various continents)

This company also provides solutions for other industrial applications.
Please, visit the following links for more info:

We have successfully characterised all known twenty Riemerella anatipestifer serotypes and have already discovered seven new, unknown serotypes.

Our experience and very close collaboration with veterinaries and molecular biologists in different companies and institutions has allowed us to accumulate a substantial stock collection. This enables us to produce on demand autogenous / autologous vaccines in less than 2 weeks from the date of diagnosis.

Economic background
New techniques in farming have resulted in the resurgence of traditional bacteriological infectious diseases in animal flocks. This is also due to the introduction of organic farming techniques and the reduction in the use of antibiotics and nutritional supplements. The answer to this challenge is the application of specific vaccines that are developed on demand. The specificity is archived by a fast diagnosis of pathogens isolated directly from the afflicted animals in the flock and the development of specific vaccines based on the pathogen present. The RIPAC - Laboratory is leading with its economic and ecological approach and delivers top quality service on demand. This policy allows us not only to serve all the specific needs of our national and international clients, but is also the basis of our research which allows us to permanently widen our pathogen diagnostics spectra by the application of modern molecular techniques.

Our philosophy
From the start, our diagnostics and the therapy strategy has been based on close collaboration with our partner veterinarians. We use the latest scientific knowledge and technology for the development of our vaccines to ensure a long term positive effect in animal health, which results in higher performance, lower half mortality rate and finally better and cheaper animal products for our clients. Following this goal, our main target is the satisfaction of our clients and their veterinarians. Our approach, which connects scientific and economical thinking, results in very high quality at competitive prices. The personal and intense contact to our clients is especially important to us as it serves as a permanent quality control and the development of long term client-veterinarian-RIPAC laboratory relationship. This is also the basis of our success in research and development of new methods in diagnosis and therapy.

With frequent follow up questionnaires and specific designed treatment-accompanying -check ups we ensure our high standard of quality and the satisfaction of our clients.

New diagnostic tests are permanently developed and introduced by us, so please do not hesitate to contact us for a consultation regarding your specific needs. As we are a company in which research and production is closely connected we are able to react very flexible to new and specific pathogens.